Extravasation of biodegradable microspheres in the rat brain

References

• Abbott NJ, Patabendige AA, Dolman DE, et al. (2010). Structure and function of the blood-brain barrier. Neurobiol Dis 37:1–12.
   PubMed Web of Science ®Google Scholar
• Becker JB, Prendergast BJ, Liang JW. (2016). Female rats are not more variable than male rats: a meta-analysis of neuroscience studies. Biol Sex Differ 7:34.
   PubMed Web of Science ®Google Scholar
• Beduneau A, Saulnier P, Benoit JP. (2007). Active targeting of brain tumors using nanocarriers. Biomaterials 28:4947–67.
   PubMed Web of Science ®Google Scholar
• Bezemer JM, Grijpma DW, Dijkstra PJ, et al. (1999). A controlled release system for proteins based on poly(ether ester) block-copolymers: polymer network characterization. J Control Release 62:393–405.
   PubMed Web of Science ®Google Scholar
• Blanco-Blázquez V, Báez-Díaz C, Sánchez-Margallo FM, et al. (2023). Intracoronary administration of microencapsulated HGF in a reperfused myocardial infarction swine model. J Cardiovasc Dev Dis 10:86.
   PubMed Web of Science ®Google Scholar
• Blinder P, Tsai PS, Kaufhold JP, et al. (2013). The cortical angiome: an interconnected vascular network with noncolumnar patterns of blood flow. Nat Neurosci 16:889–97.
   PubMed Web of Science ®Google Scholar
• Carpentier A, Canney M, Vignot A, et al. (2016). Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med 8:343re2.
   PubMed Web of Science ®Google Scholar
• Cho KH, Ahn SJ, Cho JH, et al. (2016). The characteristics of retinal emboli and its association with vascular reperfusion in retinal artery occlusion. Invest Ophthalmol Vis Sci 57:4589–98.
   PubMed Web of Science ®Google Scholar
• Cummings J. (2018). Lessons learned from alzheimer disease: clinical trials with negative outcomes. Clin Transl Sci 11:147–52.
   PubMed Web of Science ®Google Scholar
• Georgakopoulou T, van der Wijk AE, Bakker E, vanBavel E. (2021). Recovery of hypoxic regions in a rat model of microembolism. J Stroke Cerebrovasc Dis 30:105739.
   PubMed Web of Science ®Google Scholar
• Giugliani R, Giugliani L, de Oliveira Poswar F, et al. (2018). Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial. Orphanet J Rare Dis 13:110.
   PubMed Web of Science ®Google Scholar
• Grutzendler J, Murikinati S, Hiner B, et al. (2014). Angiophagy prevents early embolus washout but recanalizes microvessels through embolus extravasation. Sci Transl Med 6:226ra31.
   PubMed Web of Science ®Google Scholar
• Hughes P, Rivers H, Shen J, et al. Poly-dioxanone multi-block copolymer for ocular protein delivery. World Intellectual Property Organization, International publication number WO2021/067388, 2021. Available at: https://nl.espacenet.com, [last accessed 14 September 2022].
   Google Scholar
• Jacus MO, Daryani VM, Harstead KE, et al. (2016). Pharmacokinetic properties of anticancer agents for the treatment of central nervous system tumors: update of the literature. Clin Pharmacokinet 55:297–311.
   PubMed Web of Science ®Google Scholar
• Lam CK, Yoo T, Hiner B, et al. (2010). Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization. Nature 465:478–82.
   PubMed Web of Science ®Google Scholar
• Lam FC, Morton SW, Wyckoff J, et al. (2018). Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles. Nat Commun 9:1991.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Petruzzi P, Crocetti L. (2013). Chemoembolization of hepatocellular carcinoma. Semin Intervent Radiol 30:3–11.
   PubMed Web of Science ®Google Scholar
• Levites Y, Das P, Price RW, et al. (2006). Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J Clin Invest 116:193–201.
   PubMed Web of Science ®Google Scholar
• Lockwood NA, Hergenrother RW, Patrick LM, et al. (2010). In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings. J Biomater Sci Polym Ed 21:529–52.
   PubMed Web of Science ®Google Scholar
• Mazure CM, Swendsen J. (2016). Sex differences in Alzheimer’s disease and other dementias. Lancet Neurol 15:451–2.
   PubMed Web of Science ®Google Scholar
• Namur J, Wassef M, Millot JM, et al. (2010). Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model. J Vasc Interv Radiol 21:259–67.
   PubMed Web of Science ®Google Scholar
• Nkanga CI, Fisch A, Rad-Malekshahi M, et al. (2020). Clinically established biodegradable long acting injectables: an industry perspective. Adv Drug Deliv Rev 167:19–46.
   PubMed Web of Science ®Google Scholar
• Ospel JM, Goyal M. (2021). A review of endovascular treatment for medium vessel occlusion stroke. J Neurointerv Surg 13:623–30.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (2005). The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2:3–14.
   PubMedGoogle Scholar
• Sandker MJ, Duque LF, Redout EM, et al. (2018). Degradation, intra-articular biocompatibility, drug release, and bioactivity of tacrolimus-loaded poly(d-l-lactide-PEG)-b-poly(l-lactide) multiblock copolymer-based monospheres. ACS Biomater Sci Eng 4:2390–403.
   PubMed Web of Science ®Google Scholar
• Sevigny J, Chiao P, Bussiere T, et al. (2016). The antibody aducanumab reduces Abeta plaques in Alzheimer’s disease. Nature 537:50–6.
   PubMed Web of Science ®Google Scholar
• Shih AY, Blinder P, Tsai PS, et al. (2013). The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit. Nat Neurosci 16:55–63.
   PubMed Web of Science ®Google Scholar
• Stanković M, Tomar J, Hiemstra C, et al. (2014). Tailored protein release from biodegradable poly(ε-caprolactone-PEG)-b-poly(ε-caprolactone) multiblock-copolymer implants. Eur J Pharm Biopharm 87:329–37.
   PubMed Web of Science ®Google Scholar
• Steendam R, Coimbra M, Ribeiro Arauja JC, Zuidema J, Henzler T, Krog A. Dosage form for extended release of an antibody or large protein. European patent office, European patent application EP4051233, published September 7, 2022. Available at https://nl.espacenet.com. 2022.
   Google Scholar
• Teekamp N, Van Dijk F, Broesder A, et al. (2017). Polymeric microspheres for the sustained release of a protein-based drug carrier targeting the PDGFβ-receptor in the fibrotic kidney. Int J Pharm 534:229–36.
   PubMedGoogle Scholar
• U.S. Food & Drug Administration (FDA). (2021). Availableat: https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug.
   Google Scholar
• van der Wijk AE, Georgakopoulou T, Majolée J, et al. (2020). Microembolus clearance through angiophagy is an auxiliary mechanism preserving tissue perfusion in the rat brain. Acta Neuropathol Commun 8:195.
   PubMed Web of Science ®Google Scholar
• van der Wijk AE, Lachkar N, de Vos J, et al. (2019). Extravasation of microspheres in a rat model of silent brain infarcts. Stroke 50:1590–4.
   PubMed Web of Science ®Google Scholar
• Zandstra J, van Beuge MM, Zuidema J, et al. (2015). Microsphere-based rapamycin delivery, systemic versus local administration in a rat model of renal ischemia/reperfusion injury. Pharm Res 32:3238–47.
   PubMed Web of Science ®Google Scholar